Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05980884
NA

Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

The risk of cardiovascular diseases from red meat consumption varies among individuals due to variations in gut microbiota. L-carnitine in red meat can be converted to TMAO in the body by certain bacteria. Not everyone experiences a significant increase in TMAO levels after consuming carnitine. Gut microbiota differences are observed between high and low TMAO producers. The presence of the gbu gene in gut microbiota is linked to TMAO production. This clinical research aims to determine if the gbu gene can predict TMAO levels after dietary carnitine intake.

Official title: Evaluation of Microbial-derived TMAO Production From Carnitine Intake by Testing Fecal Gbu Gene

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

230

Start Date

2023-07-24

Completion Date

2026-07-30

Last Updated

2026-01-12

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

L-carnitine

Participants are required to take a capsule containing 500mg L-carnitine/day continuous for 7-10 days.

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan